Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for March 2004
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

France pours cold water on Novartis talks
Novartis want neutral position from government..(more)

 Solvay and Altana to swap detailing time
Agreement should maintain strong product growth..(more)

 Bayer feels cost of restructuring
Bayer posts record losses..(more)

 Celltech closer to finding new partner for arthritis drug
Four candidates shortlisted..(more)

 Networks could transform UK medical research
Extra £200 million to be invested by 2008..(more)

 Pfizer and Haringey PCT to collaborate on chronic disease initiative
Pfizer pilot disease management in London borough..(more)

 UK and US face up to public health crises
Countries tackle public heatlh head-on..(more)

 New code for journals in wake of MMR conflict of interest
BMJ editor draws up medical journal code of conduct..(more)

 NHS staff shortages hamper PCT progress
New government campaign supports recruitment drive..(more)

 Salesforce challenger wins record contract
AmDel awarded Lundbeck contract..(more)

 Serious concerns could delay Zocor switch
Doctors express OTC doubts..(more)

 Crestor team prepares for next round of UK statin battle
Two new competitors for Crestor in its second year..(more)

 Novartis ponders tie-up with Aventis
Aventis looking for 'white knight'..(more)

 Cameron appointment steadies Acambis
Acambis carries out strategic review..(more)

 Elan fall-out provides launch pad for new company
Sir Richard Sykes appointed chairman..(more)

 Parallel trade shows decline for the first time
UK and Germany growth declines..(more)

 MMR researchers withdraw claim
Doctors distance themselves from controversy..(more)

 McClellan's new job stirs political controversy
Departure blow for FDA..(more)

 Renamed agency takes on OTC Zocor account
Ozone takes on Zocor Heart Pro..(more)

 Yamanouchi to buy rivals Fujisawa for $7 billion
Merger to take effect April 2005..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.